InspireMD Files 8-K on Officer/Director Changes
Ticker: NSPR · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K |
| Filed Date | Sep 17, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $180,000, $120,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
InspireMD 8-K: Leadership changes and compensation details filed Sept 17.
AI Summary
InspireMD, Inc. filed an 8-K on September 17, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits, with the earliest event reported being September 13, 2025.
Why It Matters
This 8-K filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- September 13, 2025 (date) — Earliest event reported
- September 17, 2025 (date) — Filing date
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided text.
Are there any new compensatory arrangements for officers detailed in this filing?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specifics of these arrangements are not included in the provided text.
What is the significance of the 'Regulation FD Disclosure' mentioned in the filing?
Regulation FD disclosures ensure that material non-public information is broadly disseminated to the public, preventing selective disclosure.
What financial statements or exhibits are included with this 8-K filing?
The filing indicates 'Financial Statements and Exhibits' are included, but the specific content of these exhibits is not detailed in the provided text.
When was InspireMD, Inc. incorporated and what is its fiscal year end?
InspireMD, Inc. was incorporated in Delaware and its fiscal year ends on December 31.
Filing Stats: 1,399 words · 6 min read · ~5 pages · Grade level 11.2 · Accepted 2025-09-17 08:00:33
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NSPR The Nasdaq
- $180,000 — value of such grant being approximately $180,000 and allocated 75% in Restricted Stock a
- $120,000 — in an aggregate amount of approximately $120,000 allocated 75% in common stock and 25% i
Filing Documents
- form8-k.htm (8-K) — 50KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- 0001493152-25-013828.txt ( ) — 253KB
- nspr-20250913.xsd (EX-101.SCH) — 3KB
- nspr-20250913_lab.xml (EX-101.LAB) — 33KB
- nspr-20250913_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: September 17, 2025 By: /s/ Marvin Slosman Name: Marvin Slosman Title: Chief Executive Officer